| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 2710-2716, Copyright © 1992 by Endocrine Society
ARTICLES |
L Olsen, U Knigge and J Warberg
Department of Medical Physiology C, Panum Institute, University of Copenhagen, Denmark.
Gastrin-releasing peptide (GRP; mammalian bombesin) may be involved in the neuroendocrine regulation of pituitary hormone secretion. We investigated the effect of GRP on ACTH secretion in conscious male rats. GRP (7-700 pmol) stimulated ACTH secretion dose-dependently after intracerebroventricular (icv) administration but had no effect after iv administration. GRP infused icv in a dose of 7 pmol, which alone increased ACTH 1.5-fold, potentiated the ACTH-releasing effect of arginine vasopressin (AVP; 80 pmol iv) and corticotropin-releasing hormone (CRH; 100 pmol iv). A higher dose of GRP (70 pmol icv), which stimulated ACTH secretion 2-fold, potentiated the effect of 80 and 400 pmol AVP iv, but had only additive effect on the ACTH response to 800 pmol AVP iv or 100 pmol CRH iv. GRP infused iv in a dose of 210 pmol, which in itself had no effect on ACTH secretion, potentiated the ACTH- stimulating effect of AVP and CRH approximately 2.5-fold. The effect of GRP (icv or iv) on AVP or CRH-stimulated ACTH release was only slightly smaller than the effect of combined administration of AVP and CRH (80 + 100 pmol iv). The ACTH-stimulating effect of GRP (700 pmol icv) was inhibited about 60% by pretreatment with either CRH or AVP antiserum and prevented by combined pretreatment with the antisera. The results indicate that: 1) GRP affects ACTH secretion indirectly at a suprapituitary level--possibly in the hypothalamus--by stimulating the release of AVP and CRH to the pituitary portal blood; and 2) GRP acts directly at the pituitary level to augment the effect of AVP and CRH on the corticotrophs. We suggest that GRP is involved in the multifactorial regulation of ACTH secretion.
This article has been cited by other articles:
![]() |
S. Subburaju and G. Aguilera Vasopressin Mediates Mitogenic Responses to Adrenalectomy in the Rat Anterior Pituitary Endocrinology, July 1, 2007; 148(7): 3102 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kobelt, M. Goebel, A. Stengel, M. Schmidtmann, I. R. van der Voort, J. J. Tebbe, R. W. Veh, B. F. Klapp, B. Wiedenmann, L. Wang, et al. Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R903 - R913. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rosen, J.-H. Lee, F. Cuttitta, F. Rafiqi, S. Degan, and M. E. Sunday Accelerated Thymic Maturation and Autoreactive T Cells in Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benedict, M. Hallschmid, J. Scheibner, D. Niemeyer, B. Schultes, V. Merl, H. L. Fehm, J. Born, and W. Kern Gut Protein Uptake and Mechanisms of Meal-Induced Cortisol Release J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1692 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsbeek, J. J. van Heerikhuize, J. Wortel, and R. M. Buijs A Diurnal Rhythm of Stimulatory Input to the Hypothalamo-Pituitary-Adrenal System as Revealed by Timed Intrahypothalamic Administration of the Vasopressin V1 Antagonist J. Neurosci., September 1, 1996; 16(17): 5555 - 5565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |